Skip to content

Written by Sarah Collins · Every article cited · Reviewed on a schedule

How we source
PCOSguides

PCOS Hair Loss: The Pattern, the Cause, and What Regrows It

9 min read

Written by Sarah CollinsChecked against the 2023 International Evidence-Based Guideline for the Assessment and Management of PCOSLast reviewed Published

A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.

The short answer

PCOS hair loss thins the crown and widens the centre part, the opposite of hirsutism, because androgens that thicken chin follicles shrink scalp follicles instead. A 2003 study found polycystic ovaries in 67% of women with unexplained hair thinning, versus 27% of controls. Low-dose oral minoxidil has the strongest trial evidence behind it.

What does PCOS hair loss actually look like?

A 2003 study of 89 women presenting with hair loss as their only complaint found polycystic ovaries in 67% of them versus 27% of a control group, and hirsutism in 21% versus 4% — both differences well past chance. That single finding is the reason dermatologists now treat unexplained hair thinning in a woman of reproductive age as a reason to check for PCOS, not just a scalp problem to manage in isolation.

The pattern itself is called female pattern hair loss, or androgenetic alopecia — the same underlying process as male pattern baldness, expressed differently because female scalp follicles respond to androgens by shrinking gradually rather than receding at the hairline. In practice that means:

  • Diffuse thinning across the crown, not a receding hairline or a bald spot.
  • A widening centre part — often the first sign someone notices, usually in a photo rather than a mirror.
  • Individual strands getting finer over time, so the ponytail feels thinner even before overall density visibly drops.
  • A gradual timeline — months to years, not days to weeks.

Clinicians grade the severity using a numbered visual scale, comparing your scalp to photographs that run from normal density through advanced thinning; the pilot study on combination minoxidil-spironolactone therapy staged its 100 participants this way, at a mean stage of 2.79 out of 5 at the point they sought treatment — solid evidence that most people start treatment while thinning is still moderate, not advanced.

Hair loss rarely arrives alone. If you’re still mapping which of the full range of PCOS symptoms apply to you, this one is worth placing alongside the others rather than chasing in isolation.

Is this PCOS alopecia, or a different kind of hair loss?

Androgens are only one of several things that make hair fall out, and only one of them produces this specific crown-and-part pattern. Ruling out the others matters, because they need different treatment.

Table 1 — telling PCOS-pattern hair loss apart from two common look-alikes.
TypePatternTypical triggerWhat confirms it
Female pattern hair loss (PCOS-driven)Diffuse crown thinning, widening part, gradualAndrogens acting on scalp follicles over months to yearsPattern plus elevated androgens or a PCOS diagnosis
Telogen effluviumSudden, diffuse shedding all over the scalpA stressor 2-3 months earlier: illness, surgery, crash diet, childbirth, new medicationA clear trigger in the prior 3 months; usually self-resolves within 6-9 months
Alopecia areataOne or more sharply defined round bald patchesAutoimmune, not hormonalThe circular shape itself, confirmed on exam

Nothing rules these categories out for certain except a clinician looking at your scalp, but the pattern is the first and most useful clue you can bring to that appointment.

Why does PCOS make hair fall out at all?

The same hormone that thickens hair on your chin is the one thinning it on your scalp — a contradiction that makes sense once you know how the follicle, not just the hormone, decides the outcome. Androgens bind the same receptor in every hair follicle you have, but scalp follicles and body/facial follicles are wired to respond in opposite directions: androgens switch body and facial follicles toward longer, coarser growth, and switch scalp follicles toward a shorter growth phase and a thinner shaft with every cycle. That is the whole reason hirsutism and scalp hair loss can show up in the same person from a single hormonal shift.

Insulin resistance adds a second, independent push. High circulating insulin lowers the liver’s output of sex-hormone-binding globulin (SHBG), the protein that keeps testosterone locked up and inactive — a mechanism that runs through most visible PCOS androgen symptoms, not hair loss specifically. Less SHBG means more free testosterone reaching every androgen-sensitive follicle you have, scalp included.

Does your phenotype change the picture?

Not everyone with PCOS carries the same androgen load, and hair loss tracks with the androgen picture specifically, not with cycle length or ovary appearance. If your bloodwork shows clearly elevated free testosterone alongside irregular cycles — the hyperandrogenic phenotype — scalp hair loss and hirsutism are both more likely to show up together, and androgen-lowering treatment has more to work with. If your androgens sit closer to normal and your PCOS shows up mainly through irregular cycles or ovarian appearance on ultrasound, hair loss is less likely to be androgen-driven at all, and it is worth ruling out thyroid, iron, and stress-related causes before assuming PCOS explains it. Lean PCOS is its own case: normal BMI does not mean normal androgen exposure, since some scalp follicles are simply more sensitive to a given androgen level than others regardless of weight — which is why two people with identical testosterone readings can have very different amounts of hair loss.

What actually regrows it

Nothing regrows hair that has fully miniaturised and stopped producing a visible shaft — the realistic goal of any treatment is to slow further loss and thicken what remains, not restore a scalp to its pre-thinning state.

Table 2 — treatment options for PCOS-pattern hair loss, by mechanism and evidence.
OptionHow it worksWhat the trial data shows
Topical minoxidil (2% or 5%)Extends the growth phase of the follicle; mechanism not fully understoodFDA-approved first-line option for female pattern hair loss generally
Low-dose oral minoxidilSame mechanism, systemic delivery, once-daily dosing79.7% of 148 women showed clinical improvement over a mean 9 months, at a median 1mg/day
Spironolactone (anti-androgen)Blocks the androgen receptor at the scalp follicleCombined with low-dose minoxidil, reduced shedding score by 2.6 points at 12 months in 100 women
Combined oral contraceptiveLowers ovarian androgen output, raises SHBGStandard first-line for the underlying hormonal picture; not tested against hair loss alone in isolation

The strongest recent evidence is for low-dose oral minoxidil, at doses far below the blood-pressure dose the drug was originally developed for. In a descriptive study of 148 women with female pattern hair loss, taking a median of 1mg daily for a mean of 9 months, 79.7% showed clinical improvement — 64.2% slight, 15.5% marked — and 20.3% had their loss stabilise rather than reverse. None got worse. Roughly one in five reported mild side effects, most commonly unwanted fine hair growth elsewhere on the body.

Whichever option you and a clinician land on, judge it at six months, not six weeks. Hair follicles cycle over months, and a treatment working perfectly can still look unchanged at four weeks because the visible shaft you’re checking for hasn’t grown out yet.

Does inositol cause hair loss?

No published PCOS trial has reported hair loss as a side effect of myo-inositol, at any studied dose. A 2011 clinical review of inositol safety across the PCOS trial literature found mild, dose-related gastrointestinal effects — nausea, loose stools, flatulence, mainly at the highest studied doses — as the only consistently reported adverse effect. Hair loss does not appear on that list.

The mechanistic reason this makes sense: inositol works by improving how your cells respond to insulin, not by acting on androgen receptors or the hormone pathways that drive hair follicle behaviour. It has no known route to causing hair loss the way androgens or a B12 deficiency do. If you started inositol and noticed shedding around the same time, the far more likely explanation is coincidence with a stressor — illness, a diet change, a supplement switch — or the natural, sometimes uneven course PCOS hair loss already follows, not the inositol itself.

Who this will not help

If your androgen levels are within normal range and a workup finds no clear hormonal driver, the anti-androgen and androgen-lowering options in Table 2 have less to act on, and minoxidil — which works on the follicle’s growth cycle directly, not the hormone — is the more logical starting point regardless of cause.

Hair loss that started suddenly within the last three months, rather than gradually over a year or more, is more likely telogen effluvium tied to a specific trigger than the slow PCOS pattern this article covers — and telogen effluvium usually resolves on its own once the trigger resolves, without needing hormonal treatment at all. And if you have iron deficiency, low ferritin, or an underactive thyroid alongside PCOS, those need correcting in their own right before you can tell how much of your hair loss is the androgen picture versus one of these separate, very treatable causes.

If your hair loss showed up around the same time as a metformin prescription, metformin’s actual relationship with hair — including its documented effect on vitamin B12 — is worth reading before you assume it’s the androgens. And if excess hair growth on your face or body is the symptom you’re actually trying to manage, that is a different process worth treating separately, even though it shares the same hormonal root.

Common questions

  • Is PCOS hair loss the same as hirsutism?

    No. Both come from androgens, but hirsutism is coarse hair growing on the face, chest or back, while PCOS hair loss is scalp thinning at the crown and part. The same hormone shift can cause both at once because scalp and body follicles respond to androgens in opposite directions.
  • Will my hair grow back if I treat PCOS?

    Thinning may stabilise or partly reverse — 79.7% of women improved on low-dose oral minoxidil over about 9 months in one study — but follicles that have fully miniaturised do not fully restore. Earlier treatment gives more to work with.
  • Can PCOS cause sudden, patchy hair loss?

    Not typically. PCOS-pattern loss is diffuse and gradual over months to years. Sudden shedding points to telogen effluvium from a recent stressor, and round, coin-sized bald patches point to alopecia areata — both need a different work-up.
  • Does low estrogen from PCOS cause hair loss?

    PCOS hair loss is driven by androgen excess and androgen sensitivity at the follicle, not by low estrogen. Combined oral contraceptives, which raise the estrogen-to-androgen ratio, are used partly for this reason.
  • How long before a hair loss treatment shows results?

    Judge at six months, not six weeks. In a 12-month study of combination minoxidil and spironolactone, most of the improvement in shedding score arrived in the second six months rather than the first.

Your next step

Take one clear, well-lit photo of your part line and crown today, and note the date — memory alone consistently underestimates gradual change, and a photo is the only honest baseline to compare against in six months. Bring it, along with a ferritin and thyroid check if you haven’t had one recently, to whichever clinician you see next.

More on this

Sources

  1. 1.Cela E, Robertson C, Rush K, et al. Prevalence of Polycystic Ovaries in Women with Androgenic Alopecia. Eur J Endocrinol. 2003.
  2. 2.Sinclair RD. Female Pattern Hair Loss: A Pilot Study Investigating Combination Therapy with Low-Dose Oral Minoxidil and Spironolactone. Int J Dermatol. 2018.
  3. 3.Rodrigues-Barata R, Moreno-Arrones OM, Saceda-Corralo D, et al. Low-Dose Oral Minoxidil for Female Pattern Hair Loss: A Unicenter Descriptive Study of 148 Women. Skin Appendage Disord. 2020.
  4. 4.Carlomagno G, Unfer V. Inositol Safety: Clinical Evidences. Eur Rev Med Pharmacol Sci. 2011.
  5. 5.Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023.
  6. 6.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.